Search

Author/Creator Collard, Harold R

1. A diagnostic model for chronic hypersensitivity pneumonitis. Issue 10 (31st May 2016)

Authors:
Johannson, Kerri A; Elicker, Brett M; Vittinghoff, Eric; Assayag, Deborah; de Boer, Kaïssa; Golden, Jeffrey A; Jones, Kirk D; King, Talmadge E; Koth, Laura L; Lee, Joyce S; Ley, Brett; Wolters, Paul J; Collard, Harold R
Journal:
Thorax
Issue:
Volume 71:Issue 10(2016)
Page Start:
951
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Analysis of protein-altering variants in telomerase genes and their association with MUC5B common variant status in patients with idiopathic pulmonary fibrosis: a candidate gene sequencing study. Issue 8 (August 2018)

Authors:
Dressen, Amy; Abbas, Alexander R; Cabanski, Christopher; Reeder, Janina; Ramalingam, Thirumalai R; Neighbors, Margaret; Bhangale, Tushar R; Brauer, Matthew J; Hunkapiller, Julie; Reeder, Jens; Mukhyala, Kiran; Cuenco, Karen; Tom, Jennifer; Cowgill, Amy; Vogel, Jan; Forrest, William F; Collard, Ha...
Journal:
Lancet
Issue:
Volume 6:Issue 8(2018)
Page Start:
603
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Association of hospital admission and forced vital capacity endpoints with survival in patients with idiopathic pulmonary fibrosis: analysis of a pooled cohort from three clinical trials. Issue 5 (May 2015)

Authors:
Durheim, Michael T; Collard, Harold R; Roberts, Rhonda S; Brown, Kevin K; Flaherty, Kevin R; King, Talmadge E; Palmer, Scott M; Raghu, Ganesh; Snyder, Laurie D; Anstrom, Kevin J; Martinez, Fernando J; for the IPFnet investigators, †
Journal:
Lancet
Issue:
Volume 3:Issue 5(2015)
Page Start:
388
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Association of hospital admission and forced vital capacity endpoints with survival in patients with idiopathic pulmonary fibrosis: analysis of a pooled cohort from three clinical trials. Issue 5 (May 2015)

Authors:
Durheim, Michael T; Collard, Harold R; Roberts, Rhonda S; Brown, Kevin K; Flaherty, Kevin R; King, Talmadge E; Palmer, Scott M; Raghu, Ganesh; Snyder, Laurie D; Anstrom, Kevin J; Martinez, Fernando J
Journal:
Lancet
Issue:
Volume 3:Issue 5(2015)
Page Start:
388
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials. Issue 5 (24th December 2013)

Authors:
Saketkoo, Lesley Ann; Mittoo, Shikha; Huscher, Dörte; Khanna, Dinesh; Dellaripa, Paul F; Distler, Oliver; Flaherty, Kevin R; Frankel, Sid; Oddis, Chester V; Denton, Christopher P; Fischer, Aryeh; Kowal-Bielecka, Otylia M; LeSage, Daphne; Merkel, Peter A; Phillips, Kristine; Pittrow, David; Swigri...
Other Names:
Aggarwal* Rohit author non-byline.; Ainslie Gillian author non-byline.; Alkassab Firas author non-byline.; Allanore Yannick author non-byline.; Descartes Paris author non-byline.; Anderson Marina E author non-byline.; Andonopoulos Andrew P author non-byline.; Antin-Ozerkis Danielle author non-byl...
Journal:
Thorax
Issue:
Volume 69:Issue 5(2014)
Page Start:
436
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. CXCL14 is a candidate biomarker for Hedgehog signalling in idiopathic pulmonary fibrosis. Issue 9 (1st March 2017)

Authors:
Jia, Guiquan; Chandriani, Sanjay; Abbas, Alexander R; DePianto, Daryle J; N'Diaye, Elsa N; Yaylaoglu, Murat B; Moore, Heather M; Peng, Ivan; DeVoss, Jason; Collard, Harold R; Wolters, Paul J; Egen, Jackson G; Arron, Joseph R
Journal:
Thorax
Issue:
Volume 72:Issue 9(2017)
Page Start:
780
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Design of the PF-ILD trial: a double-blind, randomised, placebo-controlled phase III trial of nintedanib in patients with progressive fibrosing interstitial lung disease. Issue 1 (17th September 2017)

Authors:
Flaherty, Kevin R; Brown, Kevin K; Wells, Athol U; Clerisme-Beaty, Emmanuelle; Collard, Harold R; Cottin, Vincent; Devaraj, Anand; Inoue, Yoshikazu; Le Maulf, Florence; Richeldi, Luca; Schmidt, Hendrik; Walsh, Simon; Mezzanotte, William; Schlenker-Herceg, Rozsa
Journal:
BMJ open respiratory research
Issue:
Volume 4:Issue 1(2017)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Efficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: a randomised, double-blind, controlled, phase 2 trial. Issue 1 (January 2017)

Authors:
Raghu, Ganesh; Brown, Kevin K; Collard, Harold R; Cottin, Vincent; Gibson, Kevin F; Kaner, Robert J; Lederer, David J; Martinez, Fernando J; Noble, Paul W; Song, Jin Woo; Wells, Athol U; Whelan, Timothy P M; Wuyts, Wim; Moreau, Emmanuel; Patterson, Scott D; Smith, Victoria; Bayly, Selina; Chien, ...
Journal:
Lancet
Issue:
Volume 5:Issue 1(2017)
Page Start:
22
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗